Salt Lake City, UT — January 9, 2018 — Predictive Technology Group, Inc. (OTC PINK: PRED), a leader in the use of data analytics for disease identification and subsequent therapeutic intervention through unique biotechnology treatments, announces that it finalized an arrangement for the acquisition of FlagshipHealth Group, a Minneapolis-based provider of sales and consulting services […]

Salt Lake City, UT — January 4, 2018 — Predictive Technology Group, Inc. (OTC PINK: PRED) announces that Dr. Hugh S. Taylor, M.D., joined the Predictive Technology Group’s Scientific Advisory Board. Predictive Technology Group, Inc., specializes in genetic testing, diagnostics, and therapeutic products to advance precision medicine. Dr. Taylor, a Chief of Obstetrics and Gynecology at Yale […]

CEO of Predictive Therapeutics and Former Wyeth Women’s Health Executive Joins Predictive Technology Group Board of Directors Salt Lake City, UT — January 2, 2018 — Predictive Technology Group, Inc. (OTC PINK: PRED), announces the appointment of Michael Dey, Ph.D. to the Board of Directors of Predictive Technology Group, Inc.  Dr. Dey will assist in corporate governance […]

Issuance Strengthens Commercialization Strategy of Company’s Gene-Based Endometriosis Diagnostics and Therapeutics Salt Lake City, UT – December 28, 2017- Predictive Technology Group, Inc. (OTC PINK: PRED), a life sciences technology holding company, announced today the issuance of U.S. patent 9,840,738 directed to treating patients genetically predisposed to endometriosis. Endometriosis, a common gynecologic disorder estimated to affect 1 in […]